Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Osteoscreen Inc (AKA: Osteo Screen Holdings Inc)
Profile last edited on: 1/29/24      CAGE: 36UN9      UEI: SULJW8MTHFF8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1996
First Award
1999
Latest Award
2005
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2040 Babcock Road Suite 201
San Antonio, TX 78229
   (210) 614-0770
   info@osteoscreen.com
   www.osteoscreen.com
Location: Single
Congr. District: 20
County: Bexar

Public Profile

In February of 2005, Osteoscreen Inc was acquired by Neosil Inc. OsteoScreen Inc. is a privately held biotechnology company that focuses on the identification and clinical development of new drugs for common diseases of bone. OsteoScreen has been funded for 14 years by licensing arrangements and joint ventures with major pharmaceutical companies.

Extent of SBIR involvement

User Avatar
Phase I Awards
9
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$897,414
Phase II Dollars
$0
Total Awarded
$897,414

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2005 1 NIH $99,171
Project Title: Novel Bisphosphonate Conjugates in Myeloma Bone Disease
2004 1 NIH $99,882
Project Title: Pharmacologically Enhanced Fracture Repair by Statins
2003 1 NIH $99,974
Project Title: Preclinical Efficacy of Epoxomicin in Myeloma
2000 1 NIH $99,309
Project Title: Development Of A Novel Agent For Treatment Of Alopecia
2000 1 NIH $99,805
Project Title: Topical Application Of Statins For Osteoporosis

Key People / Management

  Gregory R Mundy -- President

  Di Chen

  Wolfgang E Gallwitz

  Ian R Garrett

  Gloria Gutierrez

Company News

There are no news available.